Skip to main content
. 2024 Feb 26;15:1716. doi: 10.1038/s41467-024-45953-1

Fig. 2. Hazard ratio (and 95% confidence interval) of clinical sequelae compared to the control groups between 0 and 30, 31 and 90, 91 and 180, 181 and 270, 271 and 365 days of SARS-CoV-2 infection.

Fig. 2

Note: Major CVD major cardiovascular disease, Composite outcome of stroke, heart failure and coronary artery disease, ARDS acute respiratory distress syndrome, CAD coronary artery disease, ESRD end-stage renal disease. Hazard ratio (HR) and 95% confidence interval (95% CI) were estimated by Cox regression, HR > 1 (or <1) indicates patients with COVID-19 had higher (lower) risk of sequelae compared to the non-COVID-19 control cohort. Dose 0, 1, 2, 3 refers to study population who have received 0 dose, 1 dose, 2 doses, and ≥3 doses of BioNtech or CoronaVac COVID-19 vaccines, respectively.